INVAMED is a medical device manufacturer that, as company-stated, was founded in 2005 and is headquartered in Ankara, Turkey, where it designs and produces devices used across interventional cardiology, vascular, venous, and several other specialty categories. For hospital buyers, distributors, and clinicians researching device manufacturers, a company profile like this one is meant to answer a practical question: who is behind the devices, how is the company structured, and what standards govern its manufacturing. This overview draws on information the company has stated about its history, scale, and regulatory footprint.
What Does INVAMED Manufacture?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
How Does INVAMED Approach Research and Innovation?
INVAMED operates a dedicated research and development center, INVAcenter, which the company states is staffed by more than 40 biomedical engineers focused on new device development and design iteration. As company-stated, INVAMED holds more than 100 international patents across six continents, reflecting a sustained investment in original device design rather than reliance solely on established, generic device formats. The company has also received recognition as the GHP Medical Device Innovator of the Year in both 2025 and 2026, an award noted here as company-stated information. Readers can learn more about the company's structure and history at https://www.invamed.com/about and https://www.invamed.com/our-company/who-we-are.